eligible for intensive chemotherapy (IC) . HemaSphere 2019 ; 3 ( Suppl 1 ): Abstract S879 . 14. Manitta V , Zordan R , Cole-Sinclair M , The symptom burden of patients with hematological malignancy: a cross-sectional observational
Search Results
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life Care
Briony Shaw, Catriona Parker, Stephen Opat, Jake Shortt, and Peter Poon
NCCN Guidelines Insights: Survivorship, Version 1.2016
Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee W. Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, M. Alma Rodriguez, Kathryn J. Ruddy, Tara Sanft, Paula Silverman, Sophia Smith, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass
, but gave little guidance for cases of mild to moderate symptom burden, which are most common. Reviewers also suggested combining “mild adjustment disorder with depressed mood or with mixed depressed mood and anxiety” with “adjustment disorder with
Longitudinal Analysis of Severe Anxiety Symptoms in the Last Year of Life Among Patients With Advanced Cancer: Relationships With Proximity to Death, Burden, and Social Support
Siew Tzuh Tang, Jen-Shi Chen, Wen-Chi Chou, Wen-Cheng Chang, Chiao-En Wu, Chia-Hsun Hsieh, Ming-Chu Chiang, and Mei-Ling Kuo
to physical symptom burden? A study in hospitalized advanced cancer patients . Palliat Med 2007 ; 21 : 341 – 346 . 14. Vodermaier A Linden W MacKenzie R . Disease stage predicts post-diagnosis anxiety and depression only in some types
A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial
Hermioni L. Amonoo, Elizabeth Daskalakis, Emma D. Wolfe, Michelle Guo, Christopher M. Celano, Brian C. Healy, Corey S. Cutler, Joseph H. Antin, William F. Pirl, Elyse R. Park, Heather S.L. Jim, Stephanie J. Lee, Thomas W. LeBlanc, Areej El-Jawahri, and Jeff C. Huffman
C , Yuen D , Mischitelle A , Symptom burden and supportive care in patients with acute leukemia . Leuk Res 2013 ; 37 : 731 – 736 . 6. Rodin G , Yuen D , Mischitelle A , Traumatic stress in acute leukemia . Psychooncology
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Calvin G. Brouwer, Joeri A.J. Douma, Evelien J.M. Kuip, Sonja Zweegman, Niels W.C.J van de Donk, Maria T.E. Hopman, Myra E. van Linde, Henk M.W. Verheul, and Laurien M. Buffart
-related quality of life, 24 symptom burden, 25 and survival 26 compared with usual care without active symptom monitoring. In contrast to patient-reported outcomes, objective physical activity measurements with smartphones have the additional benefit of
Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies
Jeremy P. Harris, Mehr Kashyap, Jessi N. Humphreys, Daniel T. Chang, and Erqi L. Pollom
that Black Americans tend to have higher rates of schizophrenia. 52 In addition, despite lower rates overall, it is thought that non-White Americans have higher psychological symptom burden, have less access to mental care, and are less likely to
What Is the Appropriate Approach to Treating Women With Incurable Cervical Cancer?
Lois Ramondetta
primarily on decreasing symptom burden and improving QOL. All treatments for unresectable recurrence are palliative, although a short-lasting response may be expected in some patients. In these cases, cytotoxic treatment may be reasonable and should be
Representation and Outcomes of Older Adults in Practice-Changing Oncology Trials in the Era of Novel Therapies: A Guideline Appraisal
Ronald Chow, Daniel E. Lage, Grant R. Williams, Mina S. Sedrak, Joseph A. Greer, Jennifer S. Temel, and Ryan D. Nipp
cancer: a scoping literature review . J Clin Oncol 2020 ; 38 : 2558 – 2569 . 10.1200/JCO.19.02809 32250717 61. Lage DE , El-Jawahri A , Fuh CX , Functional impairment, symptom burden, and clinical outcomes among hospitalized
Comorbidities, Rather Than Older Age, Are Strongly Associated With Higher Utilization of Healthcare in Colorectal Cancer Survivors
Melissa S.Y. Thong, Daniel Boakye, Lina Jansen, Uwe M. Martens, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, and Volker Arndt
% to 62%, 4 – 6 when compared with control patients without cancer (11%–50%). 7 In addition to being associated with poorer health outcomes, such as higher symptom burden, lower health-related quality of life, and higher mortality, 8 – 11
Survivorship, Version 1.2021
Featured Updates to the NCCN Guidelines
Amye Tevaarwerk, Crystal S. Denlinger, Tara Sanft, Shannon M. Ansbaugh, Saro Armenian, K. Scott Baker, Gregory Broderick, Andrew Day, Wendy Demark-Wahnefried, Kristin Dickinson, Debra L. Friedman, Patricia Ganz, Mindy Goldman, Norah Lynn Henry, Christine Hill-Kayser, Melissa Hudson, Nazanin Khakpour, Divya Koura, Allison L. McDonough, Michelle Melisko, Kathi Mooney, Halle C.F. Moore, Natalie Moryl, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Chirayu Patel, Lindsay Peterson, William Pirl, M. Alma Rodriguez, Kathryn J. Ruddy, Lidia Schapira, Lillie Shockney, Sophia Smith, Karen L. Syrjala, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass
– 47 Other factors that affect the likelihood for employment problems include symptom burden, marital status, and emotional and functional well-being. 15 , 29 , 31 , 32 , 42 – 47 Increased employment difficulties are also seen in survivors with
